Congenital heart disease
Association of feeding modality with interstage mortality after single-ventricle palliation

https://doi.org/10.1016/j.jtcvs.2011.12.027Get rights and content
Under an Elsevier user license
open archive

Objective

Interstage mortality has been reported in 10% to 25% of hospital survivors after single-ventricle palliation. The purpose of this study was to examine the impact of feeding modality at discharge after single-ventricle palliation on interstage mortality.

Methods

We conducted a retrospective review of all neonates undergoing single-ventricle palliation from January 2003 to January 2010. A total of 334 patients (90%) survived to hospital discharge, comprising the study group. Preoperative, operative, and postoperative variables were examined, including feeding method at discharge. Multivariate Poisson regression models were constructed to estimate the relative risk of interstage mortality.

Results

Of 334 patients, 56 (17%) underwent gastrostomy tube ± Nissen. There was a statistically significant increase in interstage mortality for patients who underwent gastrostomy tube ± Nissen compared with patients who did not (relative risk, 2.38; 95% confidence interval, 1.05–5.40; P = .04]). Of the 278 patients who were not fed via a gastrostomy tube ± Nissen, 190 (68%) were fed with nasogastric feedings and 88 (32%) were fed entirely by mouth. There was no difference in interstage mortality between these 2 groups (relative risk, 0.92; 95% confidence interval, 0.31–2.73; P = .89).

Conclusions

Neonates undergoing single-ventricle palliation who require gastrostomy tube ± Nissen are at an increased risk of interstage mortality. The need for gastrostomy tube ± Nissen in this population may be a marker for other unmeasured comorbidities that place them at an increased risk of interstage mortality. Discharge with nasogastric feeds does not increase the risk of interstage mortality.

CTSNet classification

20

Abbreviations and Acronyms

CI
confidence interval
GERD
gastroesophageal reflux disease
GT
gastrostomy tube
NG
nasogastric tube
Nissen/GT
Nissen fundoplication and gastrostomy tube
PO
per os (oral)
RR
risk ratio

Cited by (0)

Disclosures: Authors have nothing to disclose with regard to commercial support.